We continue to advocate for funding stability and policy support to ensure families maintain access to high-integrity, truly better-for-you products during periods of federal uncertainty. GLP-1 users are more focused on science and labels One in eight Americans has used a GLP-1 drug like Ozempic, Wegovy or Mounjaro, and this could rise to up to 70 million people by 2028, when theyll likely have boosted the national GDP by 1%
Exposure of the general population to dichlorvos via food and drinking-water is negligible and does not constitute a health hazard
The findings of this study showed that GLP-1R, mostly expressed in BMSCs, enhances the process of osteoblast development (Habib et al
Were talking about: The push to classify retatrutide as a biologic Why that could mean pricing in the $7,000/month range How LillyDirect is changing access to tirzepatide The two lane system that could define obesity treatment going forward And what this means for patients already struggling to stay on GLP-1 therapies If youve ever fought insurance, dealt with compounding disappearing, or felt like the system decides what youre allowed to have this one is for you
Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats
